Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Check-Cap Ltd Ord (CHEK)
Check-Cap Ltd Ord (CHEK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,520
  • Shares Outstanding, K 4,820
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,110 K
  • 60-Month Beta 0.21
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.38
Trade CHEK with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.52
  • Number of Estimates 2
  • High Estimate -0.17
  • Low Estimate -0.87
  • Prior Year -0.64
  • Growth Rate Est. (year over year) +18.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.07 +7.73%
on 02/07/24
2.39 -6.69%
on 02/21/24
+0.04 (+1.83%)
since 01/22/24
3-Month
1.90 +17.37%
on 01/04/24
3.52 -36.65%
on 11/24/23
-1.09 (-32.83%)
since 11/22/23
52-Week
1.22 +82.79%
on 03/24/23
4.63 -51.78%
on 09/21/23
-1.16 (-34.22%)
since 02/22/23

Most Recent Stories

More News
SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD

/CNW/ - Symetryx Corporation ("Symetryx"), a Canadian venture company, is pleased to announce that the shareholders of Check-Cap Ltd. (NASDAQ: CHEK) voted...

CHEK : 2.23 (-6.69%)
CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL

/CNW/ - Further to its news release of November 28, 2023, Symetryx continues to urge its fellow Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) shareholders to...

CHEK : 2.23 (-6.69%)
CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

/CNW/ - Further to its news release of November 28, 2023, Symetryx continues to urge its fellow Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) shareholders to...

CHEK : 2.23 (-6.69%)
CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES

/CNW/ - Today, Symetryx Corporation ("Symetryx") once again encourages our fellow shareholders of Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) to review the...

CHEK : 2.23 (-6.69%)
Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting

/CNW/ - Symetryx, a holder of 5.6% of Check-Cap Ltd. (NASDAQ: CHEK) shares, today issued the following open letter to shareholders. In the letter Symetryx...

CHEK : 2.23 (-6.69%)
Check-Cap Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), today announced financial results for the second quarter and six months ended...

CHEK : 2.23 (-6.69%)
SYMETRYX CORP INCREASES NON-BINDING OFFER TO ACQUIRE CHECK-CAP TO $4.60 PER SHARE

/PRNewswire/ - Today, Symetryx Corporation ("Symetryx") announced an increase in price per share for our non-binding proposal to acquire common shares of...

CHEK : 2.23 (-6.69%)
SYMETRYX CORP INCREASES NON-BINDING OFFER TO ACQUIRE CHECK-CAP TO $4.60 PER SHARE

/CNW/ - Today, Symetryx Corporation ("Symetryx") announced an increase in price per share for our non-binding proposal to acquire common shares of Check-Cap...

CHEK : 2.23 (-6.69%)
Symetryx Corp. announced a non-binding proposal to acquire Check-Cap for $4.35 per share

/PRNewswire/ - Today, Symetryx Corporation ("Symetryx") announced a non-binding proposal to acquire Check-Cap LTD (NASDAQ: CHEK) ("Check") for $4.35 per share...

CHEK : 2.23 (-6.69%)
Symetryx Corp. announced a non-binding proposal to acquire Check-Cap for $4.35 per share

/CNW/ - Today, Symetryx Corporation ("Symetryx") announced a non-binding proposal to acquire Check-Cap LTD (NASDAQ: CHEK) ("Check") for $4.35 per share in cash....

CHEK : 2.23 (-6.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel.

See More

Key Turning Points

3rd Resistance Point 2.74
2nd Resistance Point 2.56
1st Resistance Point 2.48
Last Price 2.23
1st Support Level 2.22
2nd Support Level 2.04
3rd Support Level 1.96

See More

52-Week High 4.63
Fibonacci 61.8% 3.32
Fibonacci 50% 2.92
Fibonacci 38.2% 2.52
Last Price 2.23
52-Week Low 1.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar